Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1996-08-28
1998-08-04
Housel, James C.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
4242341, 435 693, 435 697, 530350, 536 237, A61K 3902
Patent
active
057889627
ABSTRACT:
Mycoplasma hyopneumoniae P65 surface antigens prepared by recombinant DNA or synthetic methods, protein antigens encoded by P65 gene, an expression vector and transformed host containing the antigens, a vaccine based on such antigens, methods of treating swine, etc. to prevent enzootic pneumonia using that vaccine and diagnostic tests to detect the presence of Mycoplasma hyopneumoniae.
REFERENCES:
patent: 5240706 (1993-08-01), Faulds
Wise et al. J. Bacteriol. 1987. 169(12):5546-5555.
Kim et al. Infect. Immun. 1990. 58(8):2637-3643.
McIntosh Mark A.
Wise Kim S.
Fishel Grace J.
Housel James C.
Shaver Jennifer
The Curators of the University of Missouri
LandOfFree
DNA sequences coding for mycoplasma hyopneumoniae surface antige does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with DNA sequences coding for mycoplasma hyopneumoniae surface antige, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and DNA sequences coding for mycoplasma hyopneumoniae surface antige will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1174294